Almirall
ALM
$6.39
-15.48%
Almonty Industries is a tungsten-focused mining company that produces tungsten concentrate from its Panasqueira tin-tungsten mine in Portugal while developing the Sangdong tungsten-molybdenum project in South Korea, alongside earlier-stage assets in Spain and Montana. It is a pure-play critical-minerals producer positioning itself as one of the few Western tungsten suppliers outside Chinese control, a niche that gives it strategic relevance far beyond its modest 342-person workforce and roughly $2.5 billion market capitalization. The investor narrative has become a tug-of-war between the structural bull case — Western governments accelerating multi-billion-dollar critical-mineral initiatives and export restrictions on strategic metals reaching record highs — and a brutal reality check in the share price, which has collapsed more than 65% over three and six months despite a positive one-year return. Recent headlines on tungsten and antimony supply security, combined with a Q3 filing that showed a large net income figure driven by non-operating items rather than mining economics, have amplified debate over whether Almonty is a genuine Sangdong-driven growth story or a momentum trade that has run ahead of its operating fundamentals.…
ALM
Almirall
$6.39
Investment Opinion: Should I buy ALM Today?
Rating: Hold (speculative, high-risk). The core thesis is that Almonty owns a genuinely scarce strategic asset — one of the few non-Chinese tungsten supply chains, with Panasqueira already shipping concentrate and Sangdong in South Korea under development — but at $6.39 the equity is priced for a Sangdong ramp that has not yet shown up in operating cash flow, with free cash flow TTM of -$44.44 million and trailing net margin of -4.98%. The unanimous six-analyst Buy consensus (ten consecutive Buy/Outperform actions from B. Riley, Stifel, DA Davidson and Oppenheimer, zero downgrades) and consensus FY EPS of $2.13 imply a forward PE of roughly 3x, but no explicit price target is disclosed in the data, so that implied upside cannot be independently verified and may be stale given the -65.48% three-month collapse.
Supporting evidence cuts both ways. On the positive side, quarterly revenue rose from $25.40 million (Q1) to $30.25 million (Q2) to $41.49 million (Q3 2026), roughly a 64% sequential increase versus an $8.70 million quarterly run-rate through 2025, with Q3 gross margin of 62.03% and operating margin of 33.72%; the balance sheet carries a 3.89 current ratio, 0.45 debt-to-equity and roughly $1.12 billion (CAD) of cash after a ~$702 million Q2 financing. On the negative side, PS of 77.34x versus a 1-2x industrial materials norm and PB of 7.03x versus 1.5-2.5x embed a 40-70x sales premium, Q3 net income of $49.76 million was driven by $42.33 million of other income (Q2's $127.93 million included $120.75 million), and consensus FY revenue of $1.21 billion is roughly 7x the annualized Q3 run-rate of ~$166 million — so the entire valuation rests on a multi-year build-out not yet demonstrated at scale.
The biggest risks that would invalidate even a Hold are (1) a Sangdong commissioning delay that pushes the revenue ramp past consensus timing, (2) continued cash burn (-$14.46 million Q3 FCF on $24.19 million capex) forcing a dilutive financing, and (3) tungsten price realization weakening if export-restriction-driven scarcity premiums ease. This Hold would upgrade to Buy if the company reports positive operating cash flow alongside revenue above roughly $60-70 million in a quarter (sustaining the sequential ramp) or if PS compresses toward 30x on delivered revenue; it would downgrade to Sell on a decisive break below the $6.39 52-week low, a missed Sangdong milestone, or a financing announced below market. Verdict: the stock is no longer expensive relative to its own history (PS 77.34x versus a 130x-364x recent range, PB 7.03x versus 8.88x-15.72x), but it remains deeply overvalued relative to sector norms and to its current cash-generating capacity — a speculative strategic-scarcity option, not a fairly valued producer.
Sign up to view all
ALM 12-Month Price Forecast
Almonty is a binary execution story trading at a deep discount to its own valuation history but a steep premium to sector norms, with the entire thesis hinging on whether Sangdong converts capex into operating cash flow. The sequential revenue ramp and 62.03% Q3 gross margin are genuine positives, and the 3.89 current ratio plus ~$1.12 billion (CAD) cash buffer mean the company is not hostage to near-term capital markets. Against that, PS of 77.34x on trailing revenue, a -$44.44 million TTM FCF, and earnings propped up by non-operating other income mean the current price already discounts substantial ramp success, while the -65.48% three-month decline and -72.72% max drawdown show how violently the market reprices when that confidence wobbles. The unanimous analyst Buy consensus is supportive but thin (six analysts on a $2.51 billion market cap) and lacks a verifiable price target, so it should be weighted cautiously. I would upgrade to bullish on confirmed positive operating cash flow and quarterly revenue above roughly $60-70 million, and downgrade to bearish on a decisive break below $6.39 or a dilutive financing announced below market.
Wall Street consensus
Six analysts cover Almonty and the coverage is uniformly bullish: the institutional ratings log shows ten consecutive Buy/Outperform actions from B. Riley, Stifel, DA Davidson, and Oppenheimer between March and October 2026, with no downgrades or Hold ratings in the dataset. Consensus FY EPS estimates average $2.13 (range $1.03 to $4.12) against a current price of $6.39, implying a forward PE of roughly 3x — a valuation that only makes sense if the Sangdong ramp delivers. However, no explicit price target is provided in the data, so implied upside to a consensus target cannot be calculated; based on the EPS estimates alone, the consensus leans strongly bullish and appears disconnected from the -65% six-month price action.\n\nThe target range is wide in earnings terms — low EPS of $1.03 versus high of $4.12, a 4x spread — signaling high uncertainty about the pace of the production ramp and tungsten price realization. The high case assumes full Sangdong commissioning, favorable tungsten pricing amid Western supply-chain reshoring, and multiple expansion on strategic-scarcity value; the low case prices in delayed ramp, margin compression from financing costs, and continued cash burn. The absence of any recent downgrade despite the collapse is notable — either analysts are anchoring on long-term contracts and strategic value, or ratings are stale — and with only six covering analysts on a $2.5 billion market cap, coverage is thin enough that price discovery may be inefficient and volatility elevated.
Bulls vs Bears: ALM Investment Factors
The bear case currently has stronger near-term evidence: the stock is pinned at its 52-week low, down 65% in three months with a -72.72% max drawdown, and the reported profits are non-operating rather than mining-driven, while free cash flow remains -$44.44 million TTM. The bull case rests on forward-looking data — a genuine sequential revenue ramp from $25.40 million to $41.49 million, gross margin of 62.03%, a 3.89 current ratio, and a unanimous six-analyst Buy consensus implying roughly 3x forward EPS. The single most important tension is whether Sangdong converts capex into operating cash flow fast enough to justify consensus revenue of $1.21 billion; if it does, the 77x PS is a growth option, and if it slips, the multiple has nowhere to hide. Until the ramp is confirmed by operating cash flow rather than other income, the risk/reward is asymmetric to the downside despite the cheap forward multiple.
Bullish
- Unanimous analyst Buy consensus: Ten consecutive Buy/Outperform actions from B. Riley, Stifel, DA Davidson and Oppenheimer between March and October 2026, with zero downgrades or Hold ratings across six covering analysts. Consensus FY EPS of $2.13 against a $6.39 price implies a forward PE of roughly 3x, an extreme discount that only persists if Sangdong fails to deliver.
- Sequential revenue ramp is real: Quarterly revenue climbed from $25.40 million in Q1 to $30.25 million in Q2 to $41.49 million in Q3 2026, roughly a 64% sequential increase, versus an $8.70 million quarterly run-rate through 2025. Q3 gross margin of 62.03% and operating margin of 33.72% show the incremental volume is arriving at attractive unit economics.
- Fortified balance sheet buys time: Current ratio of 3.89, debt-to-equity of just 0.45, and roughly $1.12 billion (CAD) of cash at Q3 end following a ~$702 million Q2 financing. This funding runway means Sangdong commissioning is not hostage to near-term capital markets access, unlike most pre-revenue critical-minerals developers.
- Strategic scarcity as a Western tungsten supplier: Almonty is one of the few non-Chinese tungsten producers, with Panasqueira already shipping concentrate and Sangdong in South Korea under development. Western governments accelerating $12 billion of critical-mineral initiatives and record export restrictions create a structural policy tailwind that is not captured in a 77x PS multiple on trailing revenue.
Bearish
- Falling knife at 52-week low: At $6.39 the stock is effectively at its 52-week low and roughly 0% of its 52-week range versus a $20.70 high, down 65.48% in three months and 65.76% in six. A -15.48% single-session drop on 11.15 million shares signals capitulation selling, not orderly mean reversion, with no historical floor below current levels.
- Valuation disconnected from current economics: PS of 77.34x versus a 1-2x industrial materials norm is a 40-70x premium, and PB of 7.03x is 3-4x the sector's 1.5-2.5x. Even if consensus revenue of $1.21 billion materializes, the stock would still trade near 2x forward sales, and trailing net margin of -4.98% and operating margin of -86.59% offer no profitability support.
- Earnings quality is non-operating: Q3 net income of $49.76 million was driven by $42.33 million of other income, and Q2's $127.93 million included $120.75 million of other income, while Q1 lost $5.26 million and Q4 2025 lost $102.27 million. Headline EPS of $0.17 and $0.45 therefore overstate mining economics, and the TTM net margin remains negative at -4.98%.
- Persistent cash burn and negative FCF: Free cash flow TTM is -$44.44 million, Q3 FCF was -$14.46 million on $24.19 million of capex, and ROE is -45.25% with a price-to-cash-flow of -131.42. The company is still consuming capital to build Sangdong and depends on the financing window staying open rather than on internal cash generation.
ALM Technical Analysis
Almonty is in a severe, sustained downtrend that has erased most of its prior gains, with the stock down 65.48% over three months and 65.76% over six months, and a maximum drawdown of -72.72% from its peak. At a current price of $6.39, the stock sits just above its 52-week low of $6.39 (the current print is effectively the low) and far below the 52-week high of $20.70 set in late May 2026 — meaning it is trading at roughly 0% of its 52-week range, a classic falling-knife configuration rather than a value entry. The lone positive data point, a +13.10% one-year change, is a stale artifact of the earlier rally and offers little comfort given the velocity of the collapse.\n\nShort-term momentum is accelerating to the downside and diverging violently from the trailing one-year figure: the stock fell 31.58% in the past month alone, including a -15.48% single-session drop from $7.56 to $6.39 on elevated volume of 11.15 million shares. Relative strength confirms broad-based underperformance — -20.81% versus SPY over one month, -55.57% over three months, and -58.27% over six months — even as the S&P itself fell 10.77% and 9.91% over those same windows, so Almonty is declining roughly three to six times faster than the market. The one-year relative strength of +7.39% is the only positive divergence and reflects the now-distant rally; the pattern of accelerating monthly losses after a multi-month slide signals capitulation-style selling rather than orderly mean reversion.\n\nKey technical levels are stark: immediate support is the current $6.39 low, and a decisive break below it would open air with no historical floor in the provided data, likely triggering further momentum-driven liquidation. Resistance sits at the $20.70 52-week high, with intermediate supply likely near the $10-$11 area where the stock consolidated in late October before breaking down. Volatility is extreme — a -72.72% max drawdown and a 15% single-day move imply realized volatility far above a beta of 1.0, and with no beta figure provided, position sizing should assume at least 2-3x market-level risk; the 6.39 print on 11.1 million shares versus a $2.51 billion market cap underscores how thin the bid has become.
Beta
—
—
Max Drawdown
-72.7%
Largest decline past year
52-Week Range
—
Price range past year
Annual Return
+13.1%
Cumulative gain past year
| Period | ALM Return | S&P 500 |
|---|---|---|
| 1m | -31.6% | -9.7% |
| 3m | -65.5% | -9.9% |
| 6m | -65.8% | -7.5% |
| 1y | +13.1% | +4.7% |
| ytd | -27.4% | +1.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ALM Fundamental Analysis
The revenue trajectory is small but inflecting: Q3 2026 revenue of $41.49 million grew 3.77% year-over-year, a sharp step-up from Q2's $30.25 million and Q1's $25.40 million, and dramatically above the $8.70 million quarterly run-rate seen through 2025. That sequential ramp — roughly 64% from Q1 to Q3 — suggests Sangdong and Panasqueira volumes are beginning to scale, though the absolute base remains tiny relative to the $2.51 billion market cap and consensus FY revenue estimates of $1.21 billion (range $730 million to $2.08 billion) imply the market expects a transformational multi-year build-out. The growth trend supports the investment case only if the ramp is sustained; a single quarter of $41 million annualizes to roughly $166 million, far below the consensus average, so execution risk is enormous.\n\nProfitability is muddied by non-operating items: Q3 net income of $49.76 million (EPS $0.17) and Q2's $127.93 million (EPS $0.45) were driven largely by other income — Q2's $120.75 million in total other income and Q3's $42.33 million — rather than mining operations, while Q1 posted a -$5.26 million loss and Q4 2025 a -$102.27 million loss. Gross margin has improved materially to 62.03% in Q3 from 51.22% in Q1 and a dismal 15.06% in Q4 2025, and operating margin reached 33.72% in Q3 versus 8.83% in Q1, but the trailing net margin of -4.98% and operating margin of -86.59% on a TTM basis show the underlying business is not yet consistently profitable. The gap between the strong quarterly gross margins and the negative trailing figures reflects one-off impairments and financing costs, so investors should focus on the operating margin trend rather than headline EPS.\n\nThe balance sheet is the strongest part of the story but cash generation is weak: the current ratio is 3.89 and cash at end of Q3 stood at roughly $1.12 billion (CAD), boosted by a massive Q2 financing that raised about $702 million in other financing activities, while debt-to-equity is a manageable 0.45. However, free cash flow TTM is -$44.44 million, Q3 FCF was -$14.46 million on $24.19 million of capex, and ROE is -45.25%, meaning the company is still burning cash to build Sangdong and depends on capital markets rather than internal funding. The $1.1 billion cash pile buys time, but with negative FCF and a -$131.42 price-to-cash-flow ratio, the company must convert capex into operating cash flow before the financing window closes.
Quarterly Revenue
$41492479.0B
2026-09
Revenue YoY Growth
+377.2%
YoY Comparison
Gross Margin
62.0%
Latest Quarter
Free Cash Flow
$-44435723.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ALM Overvalued?
Because trailing net income is negative (EPS -$0.064, trailing PE -15.50), the PE ratio is not meaningful and I have selected the price-to-sales ratio as the primary metric, supplemented by price-to-book. The PS ratio of 77.34x is extreme for any industrial materials company, and with a forward PE of 0 and a PEG of 0 (no meaningful earnings base), the market is valuing Almonty almost entirely on future Sangdong output rather than current cash flows; the negative EV/EBITDA of -85.63 confirms EBITDA is still negative on a trailing basis.\n\nAgainst a typical industrial materials sector PS of roughly 1-2x, Almonty's 77.34x represents a premium of 40-70x — an extraordinary spread that can only be justified if consensus revenue of $1.21 billion materializes, which would still leave the stock at roughly 2x forward sales. The price-to-book of 7.03x versus a sector norm of 1.5-2.5x is a 3-4x premium, and the -4.98% net margin and -86.59% operating margin are far inferior to the mid-single-digit-to-low-teens margins typical of diversified miners, so the premium is a pure strategic-scarcity and growth bet rather than a profitability premium.\n\nHistorically, Almonty's own valuation band has been volatile but consistently rich: PS ranged from 130.18x in Q3 2026 to 364.33x in Q4 2025, and PB from 8.88x to 15.72x over the same period, so the current 77.34x PS and 7.03x PB are actually near the low end of the company's own recent range — a function of the 65% price collapse rather than fundamental improvement. That positioning suggests the market has de-rated the stock sharply but still prices in optimistic Sangdong execution; a further re-rating toward sector norms would require either a dramatic revenue ramp or a continued price decline.
PE
-15.5x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
25.2x
Industry PE ~25.2x*
EV/EBITDA
-85.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are dominated by the gap between reported profit and actual mining economics. Q3 net income of $49.76 million was propped up by $42.33 million of other income, and Q2's $127.93 million included $120.75 million of other income, while Q1 lost $5.26 million and Q4 2025 lost $102.27 million, so headline EPS of $0.17 and $0.45 are not repeatable operating results. Free cash flow TTM is -$44.44 million, Q3 FCF was -$14.46 million on $24.19 million of capex, and ROE is -45.25%, meaning the company still burns cash to build Sangdong. The $1.12 billion (CAD) cash pile and 3.89 current ratio provide a buffer, but with a -$131.42 price-to-cash-flow and debt-to-equity of 0.45, the company must convert capex into operating cash flow before the financing window narrows. Market and competitive risks center on valuation compression and single-asset execution. PS of 77.34x versus a 1-2x industrial materials norm and PB of 7.03x versus 1.5-2.5x leave enormous room for multiple contraction if Sangdong slips, and the stock has already fallen 65.48% in three months and 65.76% in six while underperforming SPY by 55.57% and 58.27% over those windows. With only six covering analysts on a $2.51 billion market cap, price discovery is thin and volatility is extreme, as shown by the -15.48% single-session drop on 11.15 million shares. Tungsten price realization is also policy-dependent: the same export restrictions that create the strategic premium could ease, and no beta is provided, so position sizing should assume at least 2-3x market-level risk given the -72.72% max drawdown. The worst-case scenario is a delayed Sangdong ramp combined with continued cash burn and a financing that dilutes equity, which would force the stock below its current $6.39 52-week low with no historical floor in the data. From $6.39, a retest of the -72.72% max drawdown implies a further decline of roughly 25-30% toward the mid-$4s, and a full de-rating toward sector PS norms would be far more severe. Investors should size positions assuming a realistic -30% to -50% downside if the ramp disappoints, and treat the $6.39 level as the line that, if broken decisively, triggers momentum-driven liquidation.
FAQ
The most severe risk is execution on Sangdong: Q3 revenue of $41.49 million annualizes to roughly $166 million versus consensus FY revenue of $1.21 billion, so any commissioning delay would invalidate the entire forward valuation. Second is cash burn and dilution: free cash flow TTM of -$44.44 million and Q3 FCF of -$14.46 million on $24.19 million of capex mean the company depends on capital markets despite a 3.89 current ratio and roughly $1.12 billion (CAD) of cash. Third is earnings quality, since Q3 net income of $49.76 million included $42.33 million of other income and Q2's $127.93 million included $120.75 million, so headline EPS overstates mining economics. Fourth is market and policy risk: the stock has a -72.72% max drawdown, fell 65.48% in three months, and its strategic premium depends on Chinese export restrictions that could ease.
The 12-month forecast splits into three scenarios. The base case (55% probability) sees the ramp continue but slower than consensus, with the stock trading in a $6.39-$10.50 band as free cash flow stays negative through most of the year. The bull case (20% probability) targets $13.00-$20.70 if Sangdong commissions on schedule, tungsten prices stay elevated, and free cash flow turns positive, with the $20.70 52-week high as the ceiling. The bear case (25% probability) targets $4.00-$6.39 if Sangdong slips or a dilutive financing is required, with a retest of the -72.72% max drawdown implying a further 25-30% decline toward the mid-$4s. The base case is most likely, and its key assumption is that quarterly revenue keeps growing sequentially while gross margin holds in the 55-62% range without a dilutive raise.
The answer depends on the benchmark. Against sector norms ALM is deeply overvalued: PS of 77.34x versus a 1-2x industrial materials norm is a 40-70x premium, PB of 7.03x versus 1.5-2.5x is a 3-4x premium, and trailing PE of -15.50 and EV/EBITDA of -85.63 reflect negative earnings and EBITDA. Against its own history, however, the stock is at the low end: PS ranged from 130.18x to 364.33x and PB from 8.88x to 15.72x in recent quarters, so the 65% price collapse has already de-rated the multiple substantially. The market is effectively pricing in consensus revenue of $1.21 billion; if that materializes, the stock would trade near 2x forward sales, but if Sangdong slips, the premium has nowhere to hide.
From a risk/reward perspective, ALM is a high-risk, high-reward speculation rather than a comfortable buy at $6.39. The upside case is anchored by a unanimous six-analyst Buy consensus, consensus FY EPS of $2.13 implying roughly 3x forward PE, and a sequential revenue ramp of about 64% from $25.40 million in Q1 to $41.49 million in Q3 2026 with a 62.03% gross margin. The downside is equally concrete: free cash flow TTM of -$44.44 million, a -4.98% net margin, PS of 77.34x versus a 1-2x industrial materials norm, and a stock already down 65.48% in three months and sitting at its $6.39 52-week low. It is a reasonable buy only for investors who accept a potential -30% to -50% drawdown and want strategic exposure to non-Chinese tungsten supply, and even then only in small size with confirmation from positive operating cash flow before adding.
ALM is structurally a long-term, thesis-driven holding but trades with short-term volatility that makes it unsuitable for most traders. The investment case depends on Sangdong reaching nameplate throughput and generating positive operating cash flow, a multi-year process given that Q3 revenue of $41.49 million is far below the $1.21 billion consensus annual figure. Meanwhile the stock's -72.72% max drawdown, -15.48% single-session drop on 11.15 million shares, and 65% three-month decline show extreme realized volatility with no dividend (yield 0%) to cushion returns. A minimum holding period of 24-36 months is appropriate to span Sangdong commissioning and the first full year of positive free cash flow, and positions should be sized assuming at least 2-3x market-level risk rather than treated as a short-term momentum trade.

